Supplementary Figure S1 | Cell-free production of the human γ-secretase components: PS1CTF, Pen-2, nicastrin and Aph-1aL. (a)-(c) SEC profiles of purified human Pen-2 (a), PS1CTF (b) and nicastrin (c), produced by the conventional method. Cell-free produced human PS1CTF and Pen-2 were purified by His-affinity chromatography with the N11-tags at their Ntermini and by SEC. In the SEC elution profile, the membrane proteins were eluted as proteomicelles, before the contaminating soluble proteins with larger molecular masses. Cellfree produced human nicastrin was purified by SEC, after FLAG-affinity chromatography and anion-exchange chromatography. (d) Comparison of the production levels of Aph-1aL with and without the N-terminal SUMO-tag by the P-MF method. Each SDS-PAGE gel was visualized by Coomassie Brilliant Blue staining. proteins were co-purified by tag-affinity chromatography with the FLAG tag at the C-terminus of PS1CTF, in 50 mM Tris-HCl buffer (pH 7.0) containing 0.05% βDDM, 0.002% CHS, and 400 mM NaCl. (b) SDS-PAGE images of the T4L-PS1NTF•PS1CTF and T4L-PS1NTF•PS1CTF•Pen-2 complexes, produced by the S-MF method in the presence of Brij-78 or digitonin, and purified with the FLAG-tagged PS1CTF in the same manner as in (a).
(c) The enzymatic activity of the T4L-PS1NTF•PS1CTF•Pen-2 complex of (b) with the intramolecularly quenched fluorogenic peptide probe. The fluorescence intensity increases per minute with and without the GXGD protease inhibitor, (Z-Leu-Leu)2 ketone, are shown with black and white bars, respectively. C 10 E 5 , pentaethylene glycol decyl ether; C 10 E 8 , octaethylene glycol decyl ether; C 12 E 6 , hexaethylene glycol dodecyl ether; OG, n-octyl-β-D-glucopyranoside; NG, n-nonyl-β-D-glucopyranoside; DM, n-decyl-β-D-maltopyranoside; UDM, n-undecyl-β-D-maltopyranoside; DDM, n-dodecyl-β-D-maltopyranoside; TDM, n-tridecyl-β-D-maltopyranoside; OG-NG, octyl glucose neopentyl glycol; DM-NG, decyl maltose neopentyl glycol; CyGlu-4, 4-cyclohexyl-1-butyl-β-D-glucopyranoside; CyMal-6, 6-cyclohexyl-1-hexyl-β-D-maltopyranoside; DMHM, 2,6-dimethyl-4-heptyl-β-D-maltopyranoside; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate; BSA, bovine serum albumin. Each experiment was performed once. The gel images of (b) were processed by cropping. (a) SDS-PAGE image of the IMACeluates of human claudin-4, produced by the S-MF method in the presence of 10 mg/ml digitonin and 6.7 mg/ml egg PC or 9.5 mg/ml 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC) and 6.7 mg/ml 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). (b) The concentrations of human claudin-4 estimated from the densitometry analysis of (a), with means r S.D. (error bars); n = 3. *, p < 0.001. (c) C-CPE binding analysis of the IMAC-eluates of human claudin-4 by AlphaScreen, using 10 nM claudin-4 and 40 nM GST-C-CPE, with means r S.D. (error bars); n = 4. **, p < 0.005. 
